About Scopio Labs
Scopio Labs is a digital pathology company specializing in hematology and laboratory diagnostics. The company has developed a Full-Field imaging technology platform that revolutionizes how clinical hematology teams analyze peripheral blood smears and bone marrow aspirate samples. Their solution replaces traditional manual microscopy with fully digital workflows, capturing dynamic images at 100x resolution that allow clinicians to view thousands of cells across the entire slide—from monolayer to feathered edge. Scopio's platform includes two imaging devices: the X100 for small to medium labs (processing 15 slides per hour) and the X100HT for high-throughput environments (processing 40 slides per hour). The technology integrates AI-powered decision support for automated cell morphology analysis, including their Complete Blood Morphology (CBM) application that provides fully autonomous analysis from scan to final report. The platform addresses critical challenges in hematology labs including rising workloads, staff shortages, and the need for remote access and collaboration. Clinical studies demonstrate the technology reduces turnaround time for peripheral blood smear reviews by 60% while improving diagnostic accuracy through analysis of significantly more cells than traditional manual differentials. Scopio Labs partners with leading hematology and pathology laboratories globally, including major health systems and reference labs, to standardize morphology results and enable remote expert consultation across hospital networks.
Clinical Focus
Medical conditions and clinical areas addressed by Scopio Labs.
Who It Serves
Milestones & Awards
Recent Milestones
Development of Complete Blood Morphology (CBM) fully autonomous analysis application. Expansion of FDA clearance and CE marking for peripheral blood smear application. Clinical validation studies published in 2024.
Key Partnerships
Social & Media
Latest Updates
How AI and Digital Hematopathology Transform Bone Marrow Examination
Differential Diagnostic dilemmas: BMA to the rescue
MDS Unpacked: Diverse Hematology With Dysplasia At The Core
Whole Slide Imaging Trade-Offs in Hematopathology Diagnostics
Quality Control in Hematology Laboratories: Best Practices, Challenges, and Solutions
Company Details
Work here?
Claim this listing to update company information and connect with our audience.
Claim This ListingOfficial Sources
Similar Companies in this Market
View all 45 →
Aiforia
Aiforia provides AI-powered digital pathology solutions for clinical diagnostics and research. The company offers cloud-based deep learning tools and CE-IVD marked clinical suites for analyzing pathology images across multiple cancer types, serving pathologists, researchers, and diagnostic laboratories worldwide.
Aignostics
Aignostics develops AI-powered pathology solutions for precision medicine, specializing in tumor microenvironment analysis from H&E-stained whole slide images. The company serves life sciences companies and academic researchers with foundation models and custom analytics services.
Aiosyn
Aiosyn develops AI-powered computational pathology software that integrates into standard digital pathology workflows. The company specializes in deep learning solutions for cancer and chronic kidney disease diagnostics, serving clinical laboratories, biopharma, and CROs.
AIxMed
AIxMed develops AI-powered computational cytology platforms for cancer detection and diagnosis. The company's flagship product AIxURO analyzes urine cytology for bladder cancer, with additional platforms in development for thyroid, cervical, and lung cancer screening.
Akoya Biosciences
Akoya Biosciences, now part of Quanterix, provides spatial biology solutions for high-plex tissue analysis. The company develops instruments, assays, and software for spatial proteomics research, enabling researchers to map biomarkers at single-cell resolution in tissue samples.
Caris Life Sciences
Caris Life Sciences is a leading precision medicine company that provides comprehensive molecular profiling for cancer patients. The company combines genomic, transcriptomic, and proteomic data with AI to deliver personalized treatment insights for oncologists and patients.
CellaVision
201-500 employees
CellaVision is a world-leading provider of digital hematology microscopy solutions covering analyzers, instruments, reagents, and software. The company automates workflows in hematology laboratories of all sizes for human and animal blood and body fluid sample analysis.
Clever Culture Systems
Clever Culture Systems develops AI-powered automated microbiology culture plate reading technology for pharmaceutical and clinical laboratories. Their flagship product, APAS Independence, automates the imaging, interpretation, and reporting of microbial growth on culture plates.
Data Accuracy Notice: Company information on HealthAI Central is compiled from public sources and updated regularly. While we strive for accuracy, details such as funding figures, employee counts, and product offerings may change. We recommend verifying critical information directly with the company before making business decisions.